RT Journal Article
SR Electronic
T1 Perspectives on building sustainable newborn screening programs for sickle cell disease: Experiences from Tanzania
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.23.20218081
DO 10.1101/2020.10.23.20218081
A1 Bukini, Daima
A1 Nkya, Siana
A1 McCurdy, Sheryl
A1 Mbekenga, Columba
A1 Manji, Karim
A1 Parker, Michael
A1 Makani, Julie
YR 2020
UL http://medrxiv.org/content/early/2020/10/27/2020.10.23.20218081.abstract
AB Prevalence of Sickle Cell Disease is high in Africa, with significant public health effects to the affected countries. Many of the countries with the highest prevalence of the disease also have poor health care system, high burden of infectious diseases with many other competing healthcare priorities. Though, considerable efforts have been done to implement newborn screening for Sickle Cell Disease programs in Africa but still coverage is low. Tanzania has one of the highest birth prevalence of children with Sickle Cell Disease in Africa. Also, it is one of many other African countries to implement pilot projects for Newborn Screening for Sickle Cell Disease to assess feasibility. Several efforts have been made afterwards to continue providing the screening services as well as comprehensive care for Sickle Cell Disease. Using qualitative methods, we conducted In- Depth Interviews and Focus Group Discussions with policy makers, health care providers and families to provide an analysis of their experiences and perspectives on efforts to expand and sustain Newborn Screening for Sickle Cell Disease and related comprehensive care services in the country. Findings have demonstrated both the opportunities and challenges in the implementation and sustainability of the services in low resource settings. A key area of strengthening is full integration of the services in countries’ health care systems to facilitate coverage, accessibility and affordability of the services. However, efforts at the local level to sustain the programs are encouraging and can be used as a model in other programs implemented in low resources settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDB research support was through student small grant at MUHAS. Commonwealth Scholarship Commission funded the DB to spend 1 year at Ethox centre where analysis and initial writing of this work started.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Muhimbili University of Health and Allied Sciences Research Ethics Committee (Ref. No. 2017- 10-20/ AEC/ Vol. XII/85). Consent was sought from all participants prior to the conduct of the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData sharing not applicable as no datasets generated and/or analysed for this study. All data relevant to the study are included in the article.AfriSickleNetAfrica Sickle Cell Research NetworkARRHAmana Regional Referral HospitalBMCBugando Medical CentreDHHDistrict Health HospitalFGDsFocus Group DiscussionsGAVIGlobal Alliance for Vaccine and ImmunizationHCRLHematology Clinical Research LaboratoryHIVHuman Immunodeficiency VirusHCPHealth Care ProvidersHCFHealth Care FacilitiesIDIsIn- Depth InterviewsLMICsLow Middle Income CountriesMNHMuhimbili National HospitalMRRHMwananyamala Regional Referral HospitalNBSNewborn ScreeningPOCTPoint of Care TestingRRHRegional Referral HospitalsSCDSickle Cell DiseaseSCPSickle Cell ProgramSCPCTSickle Cell Patients Community of TanzaniaSPARCOSickle Pan African Research ConsortiumSYCFSickle Cell Youth FoundationTANSCDATanzania Sickle Cell Disease AllianceTASIWATanzania Sickle Cell WarriorsTRRHTemeke Regional Referral Hospital